Levongestrel IUD Linked to Increased Breast Cancer Risk: Danish Study

A recent study conducted by Danish researchers suggests that the use of a levonorgestrel-releasing intrauterine system (LNG-IUS) may be associated with a slightly elevated risk of breast cancer. While hormonal contraceptives offer numerous benefits, it’s crucial to understand potential risks associated with each type.

Published in JAMA, the study analyzed nationwide Danish registries, examining 78,595 women who initiated LNG-IUS between 2000 and 2019. These women were matched with a similar group who weren’t using hormonal contraceptives. Researchers tracked participants through 2022, considering factors like breast cancer diagnosis, pregnancy, hormone therapy, emigration, or death.

Methodology Breakdown

The study employed a robust methodology. Researchers utilized a Cox proportional hazards model, adjusting for variables such as previous hormonal contraceptive use, fertility drugs, age at first delivery, parity, polycystic ovarian syndrome, endometriosis, and education. This meticulous approach aimed to isolate the potential impact of LNG-IUS on breast cancer risk.

Findings: A Cautious Note

The analysis revealed a hazard ratio of 1.4 for continuous LNG-IUS use compared to non-use, indicating a 40% increased risk of breast cancer. However, it’s important to note that:

• The risk didn’t appear to increase significantly with longer duration of use.
• Other lifestyle factors, such as smoking, alcohol consumption, and obesity, are known to have a greater impact on breast cancer risk.

Expert Perspectives: Balancing Benefits and Risks

“Women should be aware that most types of hormonal contraceptives are associated with a small increased risk of breast cancer. This study adds another type of hormonal contraceptive to that list. That has to be considered with the many benefits from hormonal contraceptives,” commented Amy Berrington de Gonzalez, professor of clinical cancer epidemiology at The Institute of Cancer Research in London.

Dr. Channa Jayasena, an endocrinologist at Imperial College London, emphasizes, “Smoking, alcohol, and obesity are much more important risk factors for breast cancer than contraceptive medications. My advice for women is that breast cancer risk caused by LNG-IUS is not established but warrants a closer look.”

Key Takeaways and Next Steps

While this study raises important questions about the potential link between LNG-IUS and breast cancer, it’s crucial to remember that more research is needed to establish a definitive cause-and-effect relationship. Women considering hormonal contraceptives, including LNG-IUS, should discuss their individual risk factors and benefits with their healthcare provider to make informed decisions.

**Talk to your doctor today to learn more about the risks and benefits of various contraceptive options.**